ABOUT Us 

Advancing Precision Oncology Through Molecular Innovation

We are a molecular diagnostics–focused oncology platform dedicated to improving cancer classification through advanced transcriptomic and gene expression technologies. Our work centers on tumor tissue-of-origin identification, helping address complex clinical scenarios such as metastatic cancers and cancers of unknown primary (CUP).

By integrating molecular profiling with computational analysis, we aim to provide objective biological insight that complements traditional histopathology and strengthens diagnostic confidence.

Our Mission

Our mission is to enhance diagnostic precision in oncology by leveraging RNA-based technologies, validated gene expression signatures, and data-driven classification systems. We strive to reduce uncertainty in cancer diagnosis and support more informed therapeutic decision-making aligned with tumor biology.

What We Focus On

Molecular Tumor Origin Determination

We develop and present scientifically grounded approaches for identifying the tissue of origin using transcriptomic data and comparative molecular signatures.

Gene Expression & RNA Technologies

Through RNA-Seq and expression-based profiling methodologies, we explore molecular patterns that define cancer subtypes and guide classification strategies.

Precision Oncology Integration

Our approach supports the broader movement toward precision medicine, where molecular identity plays a central role in treatment selection and patient management.

Scientific Integrity

We prioritize analytical rigor, validation standards, and reproducibility. Our content and framework are grounded in peer-reviewed oncology research and evolving molecular diagnostic practices. We emphasize clarity, transparency, and clinical relevance in every aspect of our work.

Our Vision

We envision a future where cancer diagnosis is guided by molecular evidence as a standard of care. By aligning innovation with scientific validation, we contribute to the ongoing evolution of precision oncology and personalized cancer management